Renovaro Biosciences Stock Probability of Future Stock Price Finishing Under 0.54
| RENB Stock | 0.61 0.09 17.31% |
Renovaro |
Renovaro Biosciences Target Price Odds to finish below 0.54
The tendency of Renovaro Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to 0.54 or more in 90 days |
| 0.61 | 90 days | 0.54 | about 40.98 |
Based on a normal probability distribution, the odds of Renovaro Biosciences to drop to 0.54 or more in 90 days from now is about 40.98 (This Renovaro Biosciences probability density function shows the probability of Renovaro Stock to fall within a particular range of prices over 90 days) . Probability of Renovaro Biosciences price to stay between 0.54 and its current price of 0.61 at the end of the 90-day period is about 30.24 .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.44 indicating as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Renovaro Biosciences will likely underperform. Additionally Renovaro Biosciences has an alpha of 0.0749, implying that it can generate a 0.0749 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Renovaro Biosciences Price Density |
| Price |
Predictive Modules for Renovaro Biosciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Renovaro Biosciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Renovaro Biosciences Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Renovaro Biosciences is not an exception. The market had few large corrections towards the Renovaro Biosciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Renovaro Biosciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Renovaro Biosciences within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.07 | |
β | Beta against Dow Jones | 1.44 | |
σ | Overall volatility | 0.09 | |
Ir | Information ratio | 0.01 |
Renovaro Biosciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Renovaro Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Renovaro Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Renovaro Biosciences is way too risky over 90 days horizon | |
| Renovaro Biosciences has some characteristics of a very speculative penny stock | |
| Renovaro Biosciences appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (80.65 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Renovaro Biosciences generates negative cash flow from operations | |
| About 50.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from MacroaxisInsider: Insider Trading |
Renovaro Biosciences Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Renovaro Stock often depends not only on the future outlook of the current and potential Renovaro Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Renovaro Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 96.2 M | |
| Cash And Short Term Investments | 220.5 K |
Renovaro Biosciences Technical Analysis
Renovaro Biosciences' future price can be derived by breaking down and analyzing its technical indicators over time. Renovaro Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Renovaro Biosciences. In general, you should focus on analyzing Renovaro Stock price patterns and their correlations with different microeconomic environments and drivers.
Renovaro Biosciences Predictive Forecast Models
Renovaro Biosciences' time-series forecasting models is one of many Renovaro Biosciences' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Renovaro Biosciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Renovaro Biosciences
Checking the ongoing alerts about Renovaro Biosciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Renovaro Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Renovaro Biosciences is way too risky over 90 days horizon | |
| Renovaro Biosciences has some characteristics of a very speculative penny stock | |
| Renovaro Biosciences appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (80.65 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Renovaro Biosciences generates negative cash flow from operations | |
| About 50.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from MacroaxisInsider: Insider Trading |
Check out Renovaro Biosciences Backtesting, Renovaro Biosciences Valuation, Renovaro Biosciences Correlation, Renovaro Biosciences Hype Analysis, Renovaro Biosciences Volatility, Renovaro Biosciences History as well as Renovaro Biosciences Performance. For information on how to trade Renovaro Stock refer to our How to Trade Renovaro Stock guide.You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Renovaro Biosciences. If investors know Renovaro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Renovaro Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.98) | Return On Assets (0.15) | Return On Equity (0.90) |
The market value of Renovaro Biosciences is measured differently than its book value, which is the value of Renovaro that is recorded on the company's balance sheet. Investors also form their own opinion of Renovaro Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Renovaro Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Renovaro Biosciences' market value can be influenced by many factors that don't directly affect Renovaro Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Renovaro Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Renovaro Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Renovaro Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.